key: cord-0815935-lw2eg9uh
authors: Kernberg, Annessa; Foraker, Randi; Carter, Ebony B.; Kelly, Jeannie C.; Odibo, Anthony O.; Raghuraman, Nandini
title: The effect of COVID-19 on Influenza treatment: a comparative analysis using synthetic and real data
date: 2022-01-31
journal: American Journal of Obstetrics and Gynecology
DOI: 10.1016/j.ajog.2021.11.274
sha: f1a10ea56127b169fcbe2d693941042a9db28937
doc_id: 815935
cord_uid: lw2eg9uh

nan

OBJECTIVE: Uptake of the SARS-COV-2 vaccine remains low in the obstetric population. We conducted a survey of high-risk obstetrical patients to assess the relationship between patient characteristics and their views regarding vaccination against COVID-19. STUDY DESIGN: A 16-item survey was distributed in two high risk obstetrics clinics at a tertiary care center from June 1 to July 20, 2021. Only individuals who were not vaccinated were offered the survey. The survey included questions related to medical history, flu vaccination, and occupation, as well concerns regarding the COVID-19 infection and vaccination. Demographics and Area Deprivation index (ADI) were compared between patients who reported willingness to receive the vaccine, those who declined, and those who were unsure. A high ADI is reflective of disadvantaged neighborhoods. Statistical analysis included Pearson X 2 test for categorical variables, one-way ANOVA or Kruskal-Wallis chi-squared for continuous variables, with a statistical significance of p < 0.05. RESULTS: 101 of 103 patients completed the survey (98% response rate). 10 (10%) reported that they would accept the mRNA COVID-19 vaccine, 59 (58%) would decline, and 32 (32%) were unsure. 61% of those who would decline and 69% of those who were unsure selfidentified as African American compared to 40% of those who would accept the vaccine (p < 0.00, Table 1 ). Among all patients, 58 (57%) cited personal health risks during pregnancy as their biggest concern regarding the vaccine in pregnancy. The median ADI amongst those who would accept the vaccine was 59 [29, 85] compared to a median ADI of 89 [23, 100] among individuals who would decline (p¼0.002, Figure 1 ). The relationship was similar between those who would accept and those who were unsure of vaccination (ADI 59 [29, 85] v 86 [36, 99] , p¼0.005).

CONCLUSION: Among women who were unvaccinated in pregnancy, the majority would decline the vaccine due to concerns about personal health risks. African American women and women from disadvantaged neighborhoods are most likely to decline, highlighting a population of interest for vaccine education.

223 The effect of COVID-19 on Influenza treatment: a comparative analysis using synthetic and real data analytics environment in which data is derived from real-world events but remains de-identified. The original non-synthetic or real data, extracted directly from the electronic health record, was also analyzed to ensure accuracy. Baseline characteristics and rates of oseltamivir administration over time were compared. RESULTS: 11,850 individuals were included in this analysis with 10,021 in the Pre-Mandate group and 1, 829 in the Post-Mandate group. The Pre-Mandate and Post-Mandate groups were statistically different with regard to race, body mass index (BMI), and mode of delivery (p < 0.05, Table 1 ). The yearly Oseltamavir administration rates between March 2016 and March 2020 averaged at 3/100,000. After the stay-at-home order, the proportion of pregnant individuals given Oseltamivir was 0/100,000 which was statistically different than the previous yearly administration rates (p ¼ 0.02, Figure 1 ). The synthetic and real data yielded the same estimates and conclusions. CONCLUSION: Administration of Oseltamivir to pregnant individuals dramatically decreased post-mandate, suggesting that stay-at-home orders may also have prevented the spread of the influenza virus. Future evaluations could include whether other anti-contagion strategies, such as mask-wearing, have an impact on health outcomes among pregnant individuals.

224 Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2

Levels of anti-SARS-CoV-2 nucleocapsid IgG, spike IgG and spike-IgM were tested in maternal and cord blood at delivery, and neonatal nasopharyngeal swabs were subjected to PCR testing. The primary endpoint was the rate of vertical transmission, defined as either positive neonatal IgM, positive neonatal IgG with sero-negative mother or positive neonatal PCR. The rate of vertical transmission was estimated to be 7% when defined by RT-PCR. Assuming that using serology tests increases the rate to 10% versus 0% in noninfected population, 71 women were required (80% power, 5% onesided alpha) RESULTS: Among 72 women, 36 (50%), 39 (54%) and 30 (42%) were positive for anti-spike-IgM, anti-spike-IgG and anti-nucleocapsid-IgG, respectively (p < 0.0001 for IgG antibodies; table)

CONCLUSION: The rate of vertical transmission was at least 11%. Vaccination should be considered 3 months post-infection in pregnant women due to a decline in antibody levels